Alaunos Therapeutics | ZIOP - Ativo Circulante





Ativo Circulante Alterar Data
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
Baxter International USD 6.99B 142M 2026-06
Biogen USD 7.31B 1.88B 2026-06
Bioline Rx USD 21.58M 2.1M 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Celltrion KRW 481.57B 10.97B 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Curis USD 6.92M 7.5M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.56B 202M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
J&J USD 59.77B 601M 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Merck USD 35.02B 8.5B 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Novartis USD 27.35B 744M 2026-06
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pfizer USD 42.82B 76M 2026-03
Pharma Mar EUR 273.45M 9.96M 2026-03
PTC Therapeutics USD 2.62B 363.36M 2026-06
Qiagen NV USD 1.54B 454.82M 2026-03
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sartorius EUR 1.64B 280M 2026-06
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
TG Therapeutics USD 1.09B 456.2M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Verastem USD 223.41M 69.36M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03